XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Consolidated net loss $ (15,487) $ (11,952)
Other comprehensive loss:    
Change in unrealized gain (loss) on available-for-sale investments, net of tax (84) 185
Comprehensive loss (15,571) (11,767)
Comprehensive (gain) loss attributable to noncontrolling interest in Pangu BioPharma Limited (4) 1
Comprehensive loss attributable to aTyr Pharma, Inc. common stockholders $ (15,575) $ (11,766)